Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Pasini

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Use of the ratio of time to progression following first- and second-line therapy to document the activity of the combination of oxaliplatin with 5-fluorouracil in the treatment of colorectal carcinomaA Bonetti, M Zaninelli, R Leone, et al.
The Pharmacogenomics Journal|March 2, 2016
Genetic prediction of long-term survival after neoadjuvant chemoradiation in locally advanced esophageal cancerM Gusella, S Giacopuzzi, L Bertolaso, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|October 1, 1996
Cardiovascular characteristics in normotensive subjects with or without family history of hypertensionM L Muiesan, D Rizzoni, R Zulli, et al.
British Journal of Cancer|February 20, 2003
Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancerG Pelosi, U Pastorino, F Pasini, et al.
British Journal of Cancer|April 23, 2009
Predictors of survival and toxicity in patients on adjuvant therapy with 5-fluorouracil for colorectal cancerM Gusella, A C Frigo, C Bolzonella, et al.
Journal of Lipid Mediators and Cell Signalling|January 1, 1996
Mechanisms involved in the in vitro modification of low density lipoprotein by human umbilical vein endothelial cells and copper ionsL Cominacini, U Garbin, A De Santis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2005
High pathological response rate in locally advanced esophageal cancer after neoadjuvant combined modality therapy: dose finding of a weekly chemotherapy schedule with protracted venous infusion of 5-fluorouracil and dose escalation of cisplatin, docetaxel and concurrent radiotherapyF Pasini, G de Manzoni, C Pedrazzani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 1999
Weekly gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase II studyP Lippe, D Tummarello, M C Monterubbianesi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2000
Stage-modified international prognostic index effectively predicts clinical outcome of localized primary gastric diffuse large B-cell lymphoma. International Extranodal Lymphoma Study Group (IELSG)S Cortelazzo, A Rossi, F Roggero, et al.
Lung Cancer (Amsterdam, Netherlands)|December 18, 2001
A phase II study of induction chemotherapy with gemcitabine (G) and cisplatin (P) in locally advanced non-small cell lung cancer: interim analysisA Santo, R Pedersini, F Pasini, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Use of the ratio of time to progression following first- and second-line therapy to document the activity of the combination of oxaliplatin with 5-fluorouracil in the treatment of colorectal carcinomaA Bonetti, M Zaninelli, R Leone, et al.
The Pharmacogenomics Journal|March 2, 2016
Genetic prediction of long-term survival after neoadjuvant chemoradiation in locally advanced esophageal cancerM Gusella, S Giacopuzzi, L Bertolaso, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|October 1, 1996
Cardiovascular characteristics in normotensive subjects with or without family history of hypertensionM L Muiesan, D Rizzoni, R Zulli, et al.
British Journal of Cancer|February 20, 2003
Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancerG Pelosi, U Pastorino, F Pasini, et al.
British Journal of Cancer|April 23, 2009
Predictors of survival and toxicity in patients on adjuvant therapy with 5-fluorouracil for colorectal cancerM Gusella, A C Frigo, C Bolzonella, et al.
Journal of Lipid Mediators and Cell Signalling|January 1, 1996
Mechanisms involved in the in vitro modification of low density lipoprotein by human umbilical vein endothelial cells and copper ionsL Cominacini, U Garbin, A De Santis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2005
High pathological response rate in locally advanced esophageal cancer after neoadjuvant combined modality therapy: dose finding of a weekly chemotherapy schedule with protracted venous infusion of 5-fluorouracil and dose escalation of cisplatin, docetaxel and concurrent radiotherapyF Pasini, G de Manzoni, C Pedrazzani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 1999
Weekly gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase II studyP Lippe, D Tummarello, M C Monterubbianesi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2000
Stage-modified international prognostic index effectively predicts clinical outcome of localized primary gastric diffuse large B-cell lymphoma. International Extranodal Lymphoma Study Group (IELSG)S Cortelazzo, A Rossi, F Roggero, et al.
Lung Cancer (Amsterdam, Netherlands)|December 18, 2001
A phase II study of induction chemotherapy with gemcitabine (G) and cisplatin (P) in locally advanced non-small cell lung cancer: interim analysisA Santo, R Pedersini, F Pasini, et al.
Pageof 10